Anna K. Dewan

849 total citations
24 papers, 496 citations indexed

About

Anna K. Dewan is a scholar working on Oncology, Pathology and Forensic Medicine and Genetics. According to data from OpenAlex, Anna K. Dewan has authored 24 papers receiving a total of 496 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 8 papers in Pathology and Forensic Medicine and 5 papers in Genetics. Recurrent topics in Anna K. Dewan's work include Autoimmune Bullous Skin Diseases (7 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Urticaria and Related Conditions (4 papers). Anna K. Dewan is often cited by papers focused on Autoimmune Bullous Skin Diseases (7 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Urticaria and Related Conditions (4 papers). Anna K. Dewan collaborates with scholars based in United States, Australia and Thailand. Anna K. Dewan's co-authors include Nicole R. LeBoeuf, Douglas B. Johnson, Henry T. Quach, Jeffrey P. Zwerner, Scott R. Granter, Leena Gandhi, Fei Ye, Elizabeth J. Davis, Kristin Kathleen Ancell and Run Fan and has published in prestigious journals such as Frontiers in Immunology, Journal of the American Academy of Dermatology and JAMA Oncology.

In The Last Decade

Anna K. Dewan

21 papers receiving 492 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna K. Dewan United States 10 309 115 100 83 72 24 496
Omar Pacha United States 11 173 0.6× 73 0.6× 83 0.8× 22 0.3× 83 1.2× 29 490
A. Dadban France 11 61 0.2× 69 0.6× 129 1.3× 26 0.3× 87 1.2× 33 418
Abraham S. Kanate United States 17 376 1.2× 197 1.7× 17 0.2× 129 1.6× 126 1.8× 61 815
Muhlis Cem Ar Türkiye 14 128 0.4× 66 0.6× 16 0.2× 210 2.5× 60 0.8× 113 655
Mohamad Sobh France 14 131 0.4× 68 0.6× 45 0.5× 132 1.6× 74 1.0× 61 476
Marino Brunori Italy 16 334 1.1× 90 0.8× 16 0.2× 77 0.9× 36 0.5× 30 649
Mariëlle J. Wondergem Netherlands 12 96 0.3× 136 1.2× 24 0.2× 53 0.6× 58 0.8× 37 331
Pierre Schneider France 12 163 0.5× 90 0.8× 38 0.4× 55 0.7× 23 0.3× 20 343
Sinem Civriz Bozdağ Türkiye 10 114 0.4× 38 0.3× 26 0.3× 76 0.9× 71 1.0× 61 397
Julie Vose United States 9 188 0.6× 93 0.8× 28 0.3× 82 1.0× 40 0.6× 18 360

Countries citing papers authored by Anna K. Dewan

Since Specialization
Citations

This map shows the geographic impact of Anna K. Dewan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna K. Dewan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna K. Dewan more than expected).

Fields of papers citing papers by Anna K. Dewan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna K. Dewan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna K. Dewan. The network helps show where Anna K. Dewan may publish in the future.

Co-authorship network of co-authors of Anna K. Dewan

This figure shows the co-authorship network connecting the top 25 collaborators of Anna K. Dewan. A scholar is included among the top collaborators of Anna K. Dewan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna K. Dewan. Anna K. Dewan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Goodman, Rachel, Aleigha Lawless, Rachel Woodford, et al.. (2025). Characterizing Chronic Cutaneous Immune-Related Adverse Events Following Immune Checkpoint Inhibitors. JAMA Dermatology. 161(5). 555–555. 1 indexed citations
2.
Mukherjee, Eric, Andrew Gibson, Matthew S. Krantz, et al.. (2025). Single-cell immunopathology of recurrent acute generalized exanthematous pustulosis associated with vancomycin. Journal of Allergy and Clinical Immunology Global. 4(2). 100426–100426. 1 indexed citations
3.
Stone, Cosby A., et al.. (2022). Hypersensitivity Reactions and Immune-Related Adverse Events to Immune Checkpoint Inhibitors: Approaches, Mechanisms, and Models. Immunology and Allergy Clinics of North America. 42(2). 285–305. 6 indexed citations
4.
Chen, Steven T., et al.. (2022). Challenging Dermatologic Considerations Associated with Immune Checkpoint Inhibitors. American Journal of Clinical Dermatology. 23(5). 707–717. 7 indexed citations
5.
Asdourian, Maria S., Leah L. Thompson, T. Otto, et al.. (2022). Morphologic characteristics of cutaneous immune-related adverse events in patients receiving immune checkpoint inhibitors combined with other anticancer therapies: A multicenter retrospective study. Journal of the American Academy of Dermatology. 88(2). 474–476.
6.
Quach, Henry T., Douglas B. Johnson, Nicole R. LeBoeuf, Jeffrey P. Zwerner, & Anna K. Dewan. (2021). Cutaneous adverse events caused by immune checkpoint inhibitors. Journal of the American Academy of Dermatology. 85(4). 956–966. 92 indexed citations
7.
Ishii, Lisa E., et al.. (2021). Case Report: Infantile Urticaria as a Herald of Neonatal Onset Multisystem Inflammatory Disease With a Novel Mutation in NLRP3. Frontiers in Immunology. 12. 775140–775140. 2 indexed citations
8.
Patrinely, James R., Anna K. Dewan, & Douglas B. Johnson. (2020). The Role of Anti-PD-1/PD-L1 in the Treatment of Skin Cancer. BioDrugs. 34(4). 495–503. 20 indexed citations
9.
Singer, Sean, Sally Tan, Anna K. Dewan, et al.. (2019). Cutaneous eruptions from ibrutinib resembling epidermal growth factor receptor inhibitor–induced dermatologic adverse events. Journal of the American Academy of Dermatology. 88(6). 1271–1281. 26 indexed citations
10.
Singer, Sean, Caroline A. Nelson, Christine G. Lian, Anna K. Dewan, & Nicole R. LeBoeuf. (2019). Nonbullous pemphigoid secondary to PD-1 inhibition. JAAD Case Reports. 5(10). 898–903. 19 indexed citations
11.
Dewan, Anna K., et al.. (2019). Kaposi Sarcoma Updates. Dermatologic Clinics. 37(4). 505–517. 51 indexed citations
12.
Dewan, Anna K., Sameer Gupta, Daniel Q. Bach, et al.. (2019). Psoriasiform eruptions secondary to phosphoinositide 3-kinase inhibition. JAAD Case Reports. 5(5). 401–405. 7 indexed citations
13.
Quach, Henry T., Anna K. Dewan, Elizabeth J. Davis, et al.. (2019). Association of Anti–Programmed Cell Death 1 Cutaneous Toxic Effects With Outcomes in Patients With Advanced Melanoma. JAMA Oncology. 5(6). 906–906. 87 indexed citations
14.
Li, David G., Anna K. Dewan, Fan Xia, et al.. (2018). The ALT-70 predictive model outperforms thermal imaging for the diagnosis of lower extremity cellulitis: A prospective evaluation. Journal of the American Academy of Dermatology. 79(6). 1076–1080.e1. 14 indexed citations
15.
Zic, John A., Anna K. Dewan, Stephanie J. Lee, et al.. (2018). The Anatomic Distribution of Skin Involvement in Patients with Incident Chronic Graft-versus-Host Disease. Biology of Blood and Marrow Transplantation. 25(2). 279–286. 8 indexed citations
16.
Dewan, Anna K., et al.. (2018). Erythema elevatum diutinum-like vasculitis secondary to cocaine adulterated with levamisole. Clinical and Experimental Dermatology. 43(4). 494–496. 2 indexed citations
17.
Dewan, Anna K., Christine G. Lian, Patrick Y. Wen, et al.. (2018). Pityriasis rubra pilaris-like erythroderma secondary to phosphoinositide 3-kinase inhibition. Clinical and Experimental Dermatology. 43(8). 890–894. 9 indexed citations
18.
Dewan, Anna K., et al.. (2018). In utero development of epidermolysis bullosa acquisita. Pediatric Dermatology. 36(1). e46–e47.
19.
Li, David G., Fan Xia, Hasan Khosravi, et al.. (2018). Outcomes of Early Dermatology Consultation for Inpatients Diagnosed With Cellulitis. JAMA Dermatology. 154(5). 537–537. 49 indexed citations
20.
Fine, Jo‐David, et al.. (2017). Occurrence of Acute Cerebellar Syndrome After Topical Application of Fluorouracil. JAMA Dermatology. 153(8). 831–831. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Omar Pacha Breakdown of academic impact, for papers by A. Dadban Breakdown of academic impact, for papers by Abraham S. Kanate Breakdown of academic impact, for papers by Muhlis Cem Ar Breakdown of academic impact, for papers by Mohamad Sobh Breakdown of academic impact, for papers by Marino Brunori Breakdown of academic impact, for papers by Mariëlle J. Wondergem Breakdown of academic impact, for papers by Pierre Schneider Breakdown of academic impact, for papers by Sinem Civriz Bozdağ Breakdown of academic impact, for papers by Julie Vose
Rankless by CCL
2026